相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial
L. E. Ferri et al.
ANNALS OF ONCOLOGY (2012)
A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
Nobutoshi Ando et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen
Jun Zhao et al.
BMC CANCER (2012)
Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer
Jian Qiu et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hyperfibrinogenemia after preoperative chemoradiotherapy predicts poor response and poor prognosis in rectal cancer
Kazushige Kawai et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
A Retrospective Comparison of Docetaxel and Paclitaxel for Patients with Advanced or Recurrent Esophageal Cancer Who Previously Received Platinum-Based Chemotherapy
Ayako Mizota et al.
ONCOLOGY (2011)
The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial
V. Seebacher et al.
BRITISH JOURNAL OF CANCER (2010)
Prognostic significance of preoperative plasma fibrinogen in endometrial cancer
Fabio Ghezzi et al.
GYNECOLOGIC ONCOLOGY (2010)
Effect of Preoperative Hyperfibrinogenemia on Recurrence of Colorectal Cancer Without a Systemic Inflammatory Response
Hiroharu Yamashita et al.
WORLD JOURNAL OF SURGERY (2009)
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
Joel Tepper et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus
Hiroya Takeuchi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis
Val Gebski et al.
LANCET ONCOLOGY (2007)
Human plasma fibrinogen is synthesized in the liver
Glenys A. Tennent et al.
BLOOD (2007)
Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer
Hiroharu Yamashita et al.
BMC CANCER (2006)
Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer
H Yamashita et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2005)
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells
JS Palumbo et al.
BLOOD (2005)
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis
E Camerer et al.
BLOOD (2004)
Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: A meta-analysis of randomized clinical trials
IG Kaklamanos et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
Guidelines on fibrinogen assays
IJ Mackie et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
分享论文
